Sarcoma cancers account for an estimated 10 to 15 percent of all newly diagnosed cancers in children and young adults under the age of 20 in the United States. For this reason, there is a significant need for better therapies and new trials for pediatric sarcoma patients.
Eugenie S. Kleinerman, M.D. is Professor and Head of the Division of Pediatrics, the first women Division Head at M. D. Anderson. She is board certified in pediatrics, holds the Mosbacher Pediatrics Chair and is also a Professor of Cancer Biology. Dr. Kleinerman is internationally recognized for her scientific and clinical expertise in sarcomas, particularly osteosarcoma. Dr. Kleinerman answers some common questions about pediatric sarcoma below.